Tech Company Financing Transactions

Sanyou Biopharmaceuticals Funding Round

Huatai Zijin Investment, private investors and LH Ventures participated in a Series B funding round for Sanyou Biopharmaceuticals. The round was announced by the company on 8/4/2022.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

3/F, Building 6, No. 188 Xinjunhuan Road, Minhang District
Shanghai, 201317
CN

Phone

(400) 821-0776

Website

www.sanyoubio.com

Email Address

[email protected]

Overview

Sanyou Biopharmaceuticals Co., Ltd. is a leading international biological high-tech enterprise focusing on R&D and services of innovative antibody drugs. Our company is committed to establishing a leading high-quality, high-throughput, and integrated R&D and value transformation platform for innovative antibody drugs internationally, constructing a business ecosystem involving therapy, R&D, and diagnostic products and services, and cooperating with global biopharmaceutical, diagnostic, and drug R&D companies to make a new progress in the diagnosis and treatment of human diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Guojun Lang

        

Browse more venture capital transactions:

Prev: 8/4/2022: Atropos Health venture capital transaction
Next: 8/4/2022: Cera venture capital transaction

Share this article

Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary